PDCD1 and neoplasm: Both WT and PD-1 KO mice treated with combination immunotherapy also showed reduced tumor growth compared to WT controls (Figure 7F), indicating that PD-1 ligation by anti-PD-1 was not necessary for combination treatment efficacy.